First real-world data on safety and effectiveness of glecaprevir/pibrentasvir for the treatment of patients with chronic hepatitis C virus infection: Data from the German Hepatitis C-Registry

2018 ◽  
Vol 68 ◽  
pp. S37 ◽  
Author(s):  
T. Berg ◽  
U. Naumann ◽  
A. Stoehr ◽  
C. Sick ◽  
G. Teuber ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document